61 unknown. 61 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 61 | Unknown 61 |
Follow Depressive Disorder: new trials by email Literature Review of Depressive Disorder trials Research Report on Depressive Disorder
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Assessing Dopamine Transporter Occupancy in the Patients With Depression Brain With Toludesvenlafaxine Hydrochloride Extended-Release Tablets Using 11C-CFT Positron Emission Tomography (PET) Toludesvenlafaxine hydrochloride sustained-release tablets - Major Depressive Disorder | Phase 4 | Unknown | Shanghai Mental Health Center | 15 | 2023-09-25 | 2023-10-19 |
| Effects of Epidural Labor Analgesia With Esketamine on the Incidence of Postpartum Depression in Parturients Esketamine, Sufentanil - Postpartum Depression | Phase 4 | Unknown | Women's Hospital School Of Medicine Zhejiang University | 364 | 2023-05-01 | 2024-08-20 |
| An EEG Study of Intravenous Ketamine for Major Depression Disorder Ketamine Hydrochloride - Major Depressive Disorder | Phase 4 | Unknown | Ehave Inc. | 35 | 2023-01-01 | 2022-08-22 |
| Multi-factor Model Constraction for Early Warning and Diagnosis of MDD Omega 3 fatty acid - Major Depressive Disorder, Bipolar Disorder | Phase 4 | Unknown | Shanghai Mental Health Center | 600 | 2022-08-23 | 2022-09-07 |
| The Role of Negr1 In Modulating Neuroplasticity in Major Depression (RONIN) Venlafaxine - Major Depressive Disorder, Bipolar Affective Disorder, Currently Depressed, Moderate | Phase 4 | Unknown | Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | 30 | 2022-03-01 | 2023-11-14 |
| Effects of Esketamine on Postpartum Depression Esketamine is not added, Esketamine 0.2mg/kg, Esketamine 0.4mg/kg - Postpartum Depression | Phase 4 | Unknown | Qinghai University | 500 | 2022-02-20 | 2022-02-08 |
| Prediction of ECT Treatment Response and Reduction of Cognitive Side-effects Using EEG and Rivastigmine Rivastigmine Transdermal Product, Sham - Depressive Disorder | Phase 4 | Unknown | UMC Utrecht | 100 | 2021-09-29 | 2024-05-10 |
| Comparison of Antidepressant Augmentation With Amantadine vs Pramipexole vs Quetiapine in Treatment Resistant Depression Quetiapine, Amantadine, Pramipexole - Treatment Resistant Depression | Phase 4 | Unknown | All India Institute of Medical Sciences, Bhubaneswar | 150 | 2021-08-07 | 2023-08-22 |
| Sumor as Adjuvant Therapy in Treatment-resistant Major Depression SUMOR, Placebo - Major Depressive Disorder | Phase 4 | Unknown | Azienda Ospedaliero-Universitaria Careggi | 102 | 2021-06-01 | 2024-02-01 |
| Dexmedetomidine Adjuvant Treatment for Depressed Patients Undergoing ECT Dexmedetomidine Injection [Precedex], Normal saline - Depressive Disorder, Major | Phase 4 | Unknown | Sultan Qaboos University | 76 | 2021-06-01 | 2020-12-11 |
| Efficacy and Safety of Peropirone Hydrochloride Tablets in the Treatment of Adolescent Bipolar Disorder Depression Perospirone hydrochloride tablets, Lithium carbonate + perospirone hydrochloride, Lithium Carbonate Pill - Depressive Disorder | Phase 4 | Unknown | Shanghai Mental Health Center | 189 | 2020-11-25 | 2021-04-01 |
| Clozapine Versus Olanzapine as Treatment for Comorbid Psychotic Disorder and Substance Use Disorder Clozapine, Olanzapine - Psychosis, Substance Use Disorders | Phase 4 | Unknown | Augusta University | 100 | 2020-07-01 | 2020-03-23 |
| Study to Assess the Effects of Intranasal Ketamine Along With rTMS for Patients With Treatment-resistant Major Depressive Disorder (TRD) intranasal ketamine, rTMS treatment - Major Depressive Disorder | Phase 4 | Unknown | University of Cincinnati | 20 | 2020-05-01 | 2020-04-20 |
| A Pilot Study on Effect of add-on Sulforaphane to SSRIs and Application of Niacin Skin Flush Response Test in Major Depressive Disorder SSRIs, SSRI plus Sulforaphane - Major Depressive Disorder | Phase 4 | Unknown | Shanghai Mental Health Center | 150 | 2020-01-01 | 2021-12-08 |
| Post Marketing Study for the Evaluation of Predictix Antidepressant Clinician Software Support Tool in Prescribing Antidepressant Medication/s for the Treatment of Patients Suffering From Major Depressive Disorder Predictix Antidepressant Software tool - Major Depressive Disorder | Phase 4 | Unknown | Taliaz Ltd. | 30 | 2019-12-01 | 2019-10-24 |
| A Comparative Study on Efficacy and Safety of add-on Sulforaphane or rTMS to Escitalopram for Major Depressive Disorder With Poor Response to Initial Treatment Escitalopram+Sulforaphane, Escitalopram+rTMS, Escitalopram - Major Depressive Disorder | Phase 4 | Unknown | Shanghai Mental Health Center | 180 | 2019-11-30 | 2021-12-06 |
| Influenza Vaccine as a Novel Experimental Model of the Behavioral Immune Response in Depression Influenza Vaccine - Depression, Healthy | Phase 4 | Unknown | University of Texas at Austin | 75 | 2019-06-10 | 2019-06-27 |
| Safety of Liposom With Citalopram in Elderly Patients With Major Depressive Disorder Liposom Forte, Citalopram, Placebo - Major Depressive Disorder | Phase 4 | Unknown | Fidia Farmaceutici s.p.a. | 150 | 2019-04-18 | 2024-01-17 |
| DIMES - DIgital MEdicine Study for Adults With Schizophrenia, Bipolar I Disorder, or Major Depression Currently Using Aripiprazole ABILIFY MYCITE - Schizophrenia, Major Depressive Disorder | Phase 4 | Unknown | Durham VA Medical Center | 46 | 2019-04-04 | 2020-06-18 |
| Effects of the Addition of Metyrapone to Antidepressant Therapy in Depression With Dexamethasone Suppression Test Non-suppression. Metyrapone - Depressive Disorder, Hormone Disturbance | Phase 4 | Unknown | Centre Hospitalier Rouffach | 14 | 2018-12-22 | 2020-09-09 |
Showing 20 of 61. Sign in to see all of them.
Depressive Disorder, Major (44) · Depression (14) · Bipolar Disorder (5) · Depressive Disorder, Treatment-Resistant (5) · Anxiety Disorders (2) · Cognitive Dysfunction (2) · Depression, Postpartum (2) · Pain (2) · Psychotic Disorders (2) · Schizophrenia (2) · Sleep Initiation and Maintenance Disorders (2) · Abdominal Pain (1) · Alzheimer Disease (1) · Breast Feeding (1)
Mental Disorders (60) · Mood Disorders (60) · Behavior (14) · Behavioral Symptoms (14) · Bipolar and Related Disorders (5) · Nervous System Diseases (5) · Pathological Conditions, Signs and Symptoms (5) · Metabolic Diseases (3) · Neurocognitive Disorders (3) · Nutritional and Metabolic Diseases (3) · Pathologic Processes (3) · Signs and Symptoms (3) · Brain Diseases (2) · Central Nervous System Diseases (2)
Escitalopram (17) · Ketamine (7) · Citalopram (6) · Fluoxetine (6) · Sertraline (6) · Venlafaxine Hydrochloride (6) · Paroxetine (5) · Duloxetine Hydrochloride (4) · Fluvoxamine (4) · Desvenlafaxine Succinate (3) · Mirtazapine (3) · Quetiapine Fumarate (3) · Transcranial Magnetic Stimulation (3) · Bupropion (2) · Esketamine (2)
Shanghai Mental Health Center (7) · Sheba Medical Center (6) · Centre de Recherche de l'Institut Universitaire en santé Mentale de Montréal (2) · National Cheng-Kung University Hospital (2) · University of Sao Paulo (2) · All India Institute of Medical Sciences, Bhubaneswar (1) · Augusta University (1) · Azienda Ospedaliero-Universitaria Careggi (1) · BRC Operations Pty. Ltd. (1) · Baker Heart and Diabetes Institute (1) · Capital Clinical Research Associates, LLC (1) · Centre Hospitalier Rouffach (1) · Centre Hospitalier Universitaire Vaudois (1) · Durham VA Medical Center (1) · Ehave Inc. (1)
China (10) · United States (8) · Canada (6) · Israel (6) · Taiwan (4) · France (3) · Italy (3) · Australia (2) · Brazil (2) · Germany (2) · Mexico (2) · Netherlands (2) · South Korea (2) · Turkey (Türkiye) (2) · Austria (1)
Angelo Sambunaris, MD (1) · Anna Sverdlik, MD (1) · Anothony Cleare (1) · Anthony Harris, MD (1) · Barbara A. Cohen, PhD (1) · Bruce Russell, PhD (1) · Casas Miguel, Prof. (1) · Chantal Csajka, Prof PhD (1) · Charles Debattista, MD (1) · Ching-Kuan Wu, M.D. (1) · Chun Wang, doctor (1) · Claire Deng, M.D. (1) · Claudio N Soares, MD, PhD (1) · Con Stough, PhD (1) · Corina Velehorschi, MD (1)
PMID 27733282, PMID 10082232, PMID 10686270, PMID 1308374, PMID 15800181, PMID 17074942, PMID 18058285, PMID 18425072, PMID 19752841, PMID 19897179, PMID 20151847, PMID 20616670, PMID 21170955, PMID 21208417, PMID 21292242, PMID 21827775, PMID 21907221, PMID 22516044, PMID 22562047, PMID 22623080, PMID 22840761, PMID 23295207, PMID 23380715, PMID 23394227, PMID 23429808, PMID 23554581, PMID 23732839, PMID 23866089, PMID 23866851, PMID 23982301, PMID 24223526, PMID 24268616, PMID 24314926, PMID 24345483, PMID 24388038, PMID 24679400, PMID 24688759, PMID 24690111, PMID 24789696, PMID 24821196, PMID 24922494, PMID 24970773, PMID 25010396, PMID 25305428, PMID 25582770, PMID 25586212, PMID 25643025, PMID 25815419, PMID 25815420, PMID 25824424
2018 (1)